{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:18:03Z","timestamp":1790957883819,"version":"4.1.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/shk.0b013e3181e83204","type":"journal-article","created":{"date-parts":[[2010,6,3]],"date-time":"2010-06-03T11:07:30Z","timestamp":1275563250000},"page":"42-44","source":"Crossref","is-referenced-by-count":30,"title":["Inter-\u03b1 Inhibitor Proteins"],"prefix":"10.1097","volume":"35","author":[{"given":"Steven M.","family":"Opal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yow-Pin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Cristofaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Artenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noubar","family":"Kessimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"DelSesto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Parejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Palardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Siryaporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210213","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1432-1327.1998.2520339.x","article-title":"Inter-alpha-inhibitor-trypsin inhibitor proteoglycan family; a group of proteins binding and stabilizing the extracellular matrix.","volume":"252","author":"Bost","year":"1998","journal-title":"Eur J Biochem"},{"issue":"2","key":"R2-7-20210213","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.CCM.0000253810.08230.83","article-title":"Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: a potential clinical marker and mediator of severe sepsis.","volume":"35","author":"Opal","year":"2007","journal-title":"Crit Care Med"},{"key":"R3-7-20210213","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1086\/377642","article-title":"Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis.","volume":"188","author":"Lim","year":"2003","journal-title":"J Infect Dis"},{"key":"R4-7-20210213","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1086\/590500","article-title":"Zhou L, Zie HY, Praseedom RK: Thymosin 1- and ulinastatin-based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenem-resistant bacteria.","volume":"198","author":"Ying","year":"2008","journal-title":"J Infect Dis"},{"key":"R5-7-20210213","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0885066608326970","article-title":"Wachtell MS, Frezza EE: A new immunomodulatory therapy for severe sepsis: ulinastatin plus thymosin 1.","volume":"24","author":"Yumin","year":"2009","journal-title":"J Intensive Care Med"},{"key":"R6-7-20210213","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142728","article-title":"Anthrax toxin: receptor binding, internalization, pore formation, and translocation.","volume":"76","author":"John","year":"2007","journal-title":"Ann Rev Biochem"},{"key":"R7-7-20210213","doi-asserted-by":"crossref","first-page":"16396","DOI":"10.1016\/S0021-9258(18)42016-9","article-title":"Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Argx-x-arg and efficiently cleaves anthrax toxin protective antigen.","volume":"267","author":"Molloy","year":"2002","journal-title":"J Biol Chem"},{"issue":"8","key":"R8-7-20210213","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1128\/IAI.73.8.5101-5105.2005","article-title":"Parejo NA, Lim YP: Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication.","volume":"73","author":"Opal","year":"2005","journal-title":"Infect Immun"},{"key":"R9-7-20210213","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen.","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"R10-7-20210213","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/500148","article-title":"Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen.","volume":"193","author":"Chen","year":"2006","journal-title":"J Infect Dis"},{"key":"R11-7-20210213","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1073\/pnas.95.13.7293","article-title":"Alpha antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent.","volume":"95","author":"Jean","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-7-20210213","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.4049\/jimmunol.179.6.4187","article-title":"Inter--trypsin inhibitor attenuates complement activation and complement-induced lung injury.","volume":"179","author":"Garatzoitis","year":"2007","journal-title":"J Immunol"},{"issue":"9","key":"R13-7-20210213","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1002\/pmic.200500563","article-title":"Proteomic characterization on inter-alpha inhibitor proteins from human plasma.","volume":"6","author":"Josic","year":"2006","journal-title":"Proteomics"},{"issue":"8","key":"R14-7-20210213","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1128\/IAI.72.8.4801-4809.2004","article-title":"Murine model of pulmonary anthrax: Kinetics of dissemination, histopathology, and mouse strain susceptibility.","volume":"72","author":"Lyons","year":"2004","journal-title":"Infect Immun"},{"key":"R15-7-20210213","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1086\/644506","article-title":"Encapsulated Bacillus anthracis interacts closely with live endothelium.","volume":"200","author":"Piris-Gimenez","year":"2009","journal-title":"J Infect Dis"},{"key":"R16-7-20210213","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.4049\/jimmunol.157.6.2514","article-title":"Bacteria in the bloodstream are trapped in the liver and killed by immigrating neutrophils.","volume":"157","author":"Gregory","year":"1996","journal-title":"J Immunol"},{"issue":"17","key":"R17-7-20210213","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J: Anthrax as a biological weapon: medical and public health management.","volume":"287","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"R18-7-20210213","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax.","volume":"55","author":"Mock","year":"2001","journal-title":"Annu Rev Microbiol"},{"key":"R19-7-20210213","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1462-5822.2006.00866.x","article-title":"Contribution of toxins to the pathogenesis of inhalational anthrax.","volume":"9","author":"Tournier","year":"2007","journal-title":"Cell Microbiol"},{"issue":"2","key":"R20-7-20210213","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/IAI.69.2.1175-1177.2001","article-title":"Macrophase-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin.","volume":"69","author":"Erwin","year":"2001","journal-title":"Infect Immun"},{"key":"R21-7-20210213","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature01794","article-title":"Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin.","volume":"424","author":"Agrawal","year":"2003","journal-title":"Nature"},{"issue":"11","key":"R22-7-20210213","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1128\/IAI.72.11.6382-6389.2004","article-title":"Cytokine response to infection with Bacillus anthracis spores.","volume":"72","author":"Pickering","year":"2004","journal-title":"Infect Immun"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00024382-201101000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T11:56:37Z","timestamp":1685620597000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00024382-201101000-00007"}},"subtitle":["A Novel Therapeutic Strategy for Experimental Anthrax Infection"],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/shk.0b013e3181e83204","relation":{},"ISSN":["1073-2322"],"issn-type":[{"value":"1073-2322","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}